ArticleBMC cardiovascular disorders2026
Association between the serum sodium-to-chloride ratio and 30-day mortality following coronary artery bypass grafting: insights from the MIMIC-IV database.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbnormalities in electrolyte balance are common following coronary artery bypass grafting (CABG) and are associated with adverse outcomes. The serum sodium-to-chloride ratio has emerged as a potential prognostic marker in critical illness, but its role in predicting short-term mortality after CABG remains unclear. This study explored the relationship between the serum sodium-to-chloride ratio and 30-day mortality following CABG, aiming to assess the predictive value of the sodium-to-chloride ratio for short-term mortality and provide insights for optimizing postoperative electrolyte management.
methodsA retrospective cohort study was carried out using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, covering intensive care unit (ICU) admissions from 2008 to 2022 at the Beth Israel Deaconess Medical Center (BIDMC). The sodium-to-chloride ratio, measured within 24 h and divided into tertiles, was the exposure variable, while 30-day mortality was the outcome. Covariates included demographics, comorbid conditions, physiological scores, vital signs, and laboratory results. Multivariable Cox regression, restricted cubic splines (RCS), subgroup analyses, and doubly robust estimation (IPTW combined with Cox regression) were used to evaluate the independent association, dose–response relationship, and the robustness of the results.
resultsPatients in the highest tertile of sodium-to-chloride ratio had a significantly higher risk of 30-day mortality than those in the lowest tertile. In the fully adjusted model, each 0.01-unit increase in the sodium-to-chloride ratio was associated with a 6% higher mortality risk (HR = 1.06, 95% CI: 1.02–1.11). Kaplan–Meier analysis showed lower survival rates in the highest tertile (p = 0.038). RCS demonstrated a significant association between the sodium-to-chloride ratio and 30-day mortality (P for overall = 0.011), with no evidence of non-linearity (P for non-linearity = 0.565), suggesting a linear relationship. Subgroup analysis showed a significant interaction in the MBP subgroup (p for interaction < 0.05), but not in other subgroups. Sensitivity analysis using doubly robust estimation yielded consistent results.
conclusionsAn elevated serum sodium-to-chloride ratio within 24 h is independently associated with increased 30-day mortality after CABG, showing a linear dose–response relationship. These findings can guide clinicians in optimizing electrolyte management strategies to improve the short-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.